OutSee Completes Seed Funding Round and Establishes Partnership With o2h Discovery for Lead Drug Target Candidate

Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
Business Weekly

OutSee closes £2.5m seed round and seals o2h alliance

Cambridge-based genomics and drug discovery fledgling OutSee has closed its £2.5 million seed round and signed a strategic ...
Seeking Alpha

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

PLEASANTON, Calif. and SINGAPORE, July 17, 2025 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore ...
Hosted on MSN

Genomic identification method provides diagnoses for 145 families with rare conditions

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable by identifying complex structural genetic changes that are often missed by ...